^
BIOMARKER:
HER-2 amplification
i
Other names: ERBB2, CD340, HER-2, HER2, NEU, NGL, V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2
Entrez ID:
HER-2 amplification
Hormone Receptor Positive Breast Cancer
Trazimera (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 amplification
HER2 Positive Breast Cancer
Trazimera (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 amplification
Hormone Receptor Positive Breast Cancer
Ontruzant (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 amplification
HER2 Positive Breast Cancer
Ontruzant (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 amplification
Hormone Receptor Positive Breast Cancer
Ogivri (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 amplification
HER2 Positive Breast Cancer
Ogivri (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 amplification
Hormone Receptor Positive Breast Cancer
Kanjinti (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 amplification
HER2 Positive Breast Cancer
Kanjinti (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 amplification
Hormone Receptor Positive Breast Cancer
Herzuma (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 amplification
HER2 Positive Breast Cancer
Herzuma (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 amplification
Hormone Receptor Positive Breast Cancer
neratinib
Sensitive
:
A1
HER-2 amplification
Breast Cancer
Zercepac (trastuzumab biosimilar)
Sensitive
:
A1
HER-2 amplification
CRC
trastuzumab + pertuzumab
Sensitive
:
A2
HER-2 amplification
CRC
fam-trastuzumab deruxtecan-nxki
Sensitive
:
A2
HER-2 amplification
CRC
trastuzumab + lapatinib
Sensitive
:
A2
HER-2 amplification
Gastric Cancer
trastuzumab
Sensitive
:
B
HER-2 amplification
HER2 Positive Breast Cancer
trastuzumab
Sensitive
:
B
HER-2 amplification
Gastroesophageal Junction Adenocarcinoma
trastuzumab
Sensitive
:
B
HER-2 amplification
Gastric Cancer
lapatinib
Sensitive
:
B
HER-2 amplification
Breast Cancer
neratinib
Sensitive
:
C1
HER-2 amplification
Breast Cancer
lapatinib
Sensitive
:
C2
HER-2 amplification
Breast Cancer
tucatinib
Sensitive
:
C2
HER-2 amplification
Gastric Cancer
pembrolizumab + trastuzumab
Sensitive
:
C2
HER-2 amplification
Cholangiocarcinoma
trastuzumab
Sensitive
:
C2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our